|

Yttrium-90 (Y-90) Clinical Trials

1 actively recruiting trial

Also known as: YTTRIGA

Pipeline

Phase 1/2: 1

Top Sponsors

  • University Health Network, Toronto1

Indications

  • Liver Disease1
  • Downstaging1
  • Liver Transplant Surgery1
  • Macrovascular Invasion1
  • Hepatocellular Carcinoma (HCC)1

Other1 trial

Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.